Skip to main content
Erschienen in: Clinical and Experimental Nephrology 2/2015

01.04.2015 | Original Article

CD16+CD56+ cells are a potential culprit for hematuria in IgA nephropathy

verfasst von: Hirotsugu Iwatani, Yasuyuki Nagasawa, Ryohei Yamamoto, Kenichiro Iio, Masayuki Mizui, Arata Horii, Tadashi Kitahara, Hidenori Inohara, Atsushi Kumanogoh, Enyu Imai, Hiromi Rakugi, Yoshitaka Isaka

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Hematuria is the first manifestation of urinary abnormality in immunoglobulin A nephropathy (IgAN). Hematuria has recently been reported as a risk factor for deterioration of renal function; however, its cause remains unknown.

Methods

We analyzed the surface marker of peripheral blood mononuclear cells before and immediately after tonsillectomy in IgAN patients and controls (chronic tonsillitis or tonsillar hypertrophy) by flow cytometry and investigated the association with hematuria. To prove our hypothesis that NK cells induce hematuria, we administered IL-12, activator of NK cells, to HIGA mice. In addition, we transferred cultured NK cells to nude rats and transferred the CD16+CD56+ cells, including NK cells, that are derived from the peripheral blood of IgAN patients immediately after tonsillectomy to nude rats to assess the hematuria level and renal histology of the recipients. We also performed cytotoxicity assays against glomerular endothelial cells by NK cells.

Results

We found that IgAN patients who showed rapid deterioration of hematuria after tonsillectomy also displayed a significant increase in CD16+CD56+ cells in the peripheral blood immediately after tonsillectomy. Exogenous administration of IL-12 to HIGA mice induced hematuria. Adoptive transfer of either cells of an NK cell line, or of CD16+CD56+ cells derived from IgAN patients, into nude rats induced hematuria in the recipients. In vitro analysis showed that NK cells exert cytotoxic activity toward human glomerular endothelial cells in a dose-dependent manner.

Conclusions

CD16+CD56+ cells seem to be responsible for hematuria in IgAN.
Literatur
2.
Zurück zum Zitat Haas M. IgA nephropathy histologically resembling focal-segmental glomerulosclerosis: a clinicopathologic study of 18 cases. Am J Kidney Dis. 1996;28(3):365–71.CrossRefPubMed Haas M. IgA nephropathy histologically resembling focal-segmental glomerulosclerosis: a clinicopathologic study of 18 cases. Am J Kidney Dis. 1996;28(3):365–71.CrossRefPubMed
3.
Zurück zum Zitat Espinosa M, Ortega R, Gomez-Carrasco JM, et al. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy. Nephrol Dial Transplant. 2009;24(3):886–91.CrossRefPubMed Espinosa M, Ortega R, Gomez-Carrasco JM, et al. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy. Nephrol Dial Transplant. 2009;24(3):886–91.CrossRefPubMed
4.
Zurück zum Zitat Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29(6):829–42.CrossRefPubMed Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29(6):829–42.CrossRefPubMed
5.
Zurück zum Zitat Gutierrez E, Gonzalez E, Hernandez E, et al. Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy. Clin J Am Soc Nephrol. 2007;2(1):51–7.CrossRefPubMed Gutierrez E, Gonzalez E, Hernandez E, et al. Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy. Clin J Am Soc Nephrol. 2007;2(1):51–7.CrossRefPubMed
6.
Zurück zum Zitat Manno C, Strippoli GF, D’Altri C, et al. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis. 2007;49(6):763–75.CrossRefPubMed Manno C, Strippoli GF, D’Altri C, et al. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis. 2007;49(6):763–75.CrossRefPubMed
7.
Zurück zum Zitat Ayalon O, Hughes EA, Cresswell P, et al. Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis. Proc Natl Acad Sci USA. 1998;95(5):2435–40.CrossRefPubMedCentralPubMed Ayalon O, Hughes EA, Cresswell P, et al. Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis. Proc Natl Acad Sci USA. 1998;95(5):2435–40.CrossRefPubMedCentralPubMed
8.
Zurück zum Zitat Nogaki F, Muso E, Kobayashi I, et al. Interleukin 12 induces crescentic glomerular lesions in a high IgA strain of ddY mice, independently of changes in IgA deposition. Nephrol Dial Transplant. 2000;15(8):1146–54.CrossRefPubMed Nogaki F, Muso E, Kobayashi I, et al. Interleukin 12 induces crescentic glomerular lesions in a high IgA strain of ddY mice, independently of changes in IgA deposition. Nephrol Dial Transplant. 2000;15(8):1146–54.CrossRefPubMed
9.
Zurück zum Zitat Kobayashi I, Nogaki F, Kusano H, et al. Interleukin-12 alters the physicochemical characteristics of serum and glomerular IgA and modifies glycosylation in a ddY mouse strain having high IgA levels. Nephrol Dial Transplant. 2002;17(12):2108–16.CrossRefPubMed Kobayashi I, Nogaki F, Kusano H, et al. Interleukin-12 alters the physicochemical characteristics of serum and glomerular IgA and modifies glycosylation in a ddY mouse strain having high IgA levels. Nephrol Dial Transplant. 2002;17(12):2108–16.CrossRefPubMed
10.
Zurück zum Zitat Hotta O, Seki S, Taguma Y, et al. CD16+ and CD56+ cells as markers of necrotizing and crescentic glomerulonephritis and active IgA glomerulonephropathy. Nephron. 1991;57(2):239–40.CrossRefPubMed Hotta O, Seki S, Taguma Y, et al. CD16+ and CD56+ cells as markers of necrotizing and crescentic glomerulonephritis and active IgA glomerulonephropathy. Nephron. 1991;57(2):239–40.CrossRefPubMed
11.
Zurück zum Zitat Antonaci S, Polignano A, Ottolenghi A, et al. Redistribution of natural killer (NK) cell frequency and NK cytotoxic activity in primary IgA nephropathy. Cytobios. 1992;69(276):27–34.PubMed Antonaci S, Polignano A, Ottolenghi A, et al. Redistribution of natural killer (NK) cell frequency and NK cytotoxic activity in primary IgA nephropathy. Cytobios. 1992;69(276):27–34.PubMed
12.
Zurück zum Zitat Yildirim I, Okur E, Ciragil P, et al. Bacteraemia during tonsillectomy. J Laryngol Otol. 2003;117(8):619–23.CrossRefPubMed Yildirim I, Okur E, Ciragil P, et al. Bacteraemia during tonsillectomy. J Laryngol Otol. 2003;117(8):619–23.CrossRefPubMed
13.
Zurück zum Zitat Maintz L, Novak N. Modifications of the innate immune system in atopic dermatitis. J Innate Immun. 2011;3(2):131–41.CrossRefPubMed Maintz L, Novak N. Modifications of the innate immune system in atopic dermatitis. J Innate Immun. 2011;3(2):131–41.CrossRefPubMed
14.
Zurück zum Zitat Cox SN, Sallustio F, Serino G, et al. Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy. Kidney Int. 2012;82(5):548–60.CrossRefPubMed Cox SN, Sallustio F, Serino G, et al. Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy. Kidney Int. 2012;82(5):548–60.CrossRefPubMed
15.
Zurück zum Zitat Muso E, Yoshida H, Takeuchi E, et al. Enhanced production of glomerular extracellular matrix in a new mouse strain of high serum IgA ddY mice. Kidney Int. 1996;50(6):1946–57.CrossRefPubMed Muso E, Yoshida H, Takeuchi E, et al. Enhanced production of glomerular extracellular matrix in a new mouse strain of high serum IgA ddY mice. Kidney Int. 1996;50(6):1946–57.CrossRefPubMed
16.
Zurück zum Zitat Beziat V, Duffy D, Quoc SN, et al. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation. J Immunol. 2011;186(12):6753–61.CrossRefPubMed Beziat V, Duffy D, Quoc SN, et al. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation. J Immunol. 2011;186(12):6753–61.CrossRefPubMed
17.
Zurück zum Zitat Yago T, Tsukuda M, Fukushima H, et al. IL-12 promotes the adhesion of NK cells to endothelial selectins under flow conditions. J Immunol. 1998;161(3):1140–5.PubMed Yago T, Tsukuda M, Fukushima H, et al. IL-12 promotes the adhesion of NK cells to endothelial selectins under flow conditions. J Immunol. 1998;161(3):1140–5.PubMed
18.
Zurück zum Zitat Segawa C, Wada T, Takaeda M, et al. In situ expression and soluble form of P-selectin in human glomerulonephritis. Kidney Int. 1997;52(4):1054–63.CrossRefPubMed Segawa C, Wada T, Takaeda M, et al. In situ expression and soluble form of P-selectin in human glomerulonephritis. Kidney Int. 1997;52(4):1054–63.CrossRefPubMed
19.
Zurück zum Zitat Yoneda O, Imai T, Goda S, et al. Fractalkine-mediated endothelial cell injury by NK cells. J Immunol. 2000;164(8):4055–62.CrossRefPubMed Yoneda O, Imai T, Goda S, et al. Fractalkine-mediated endothelial cell injury by NK cells. J Immunol. 2000;164(8):4055–62.CrossRefPubMed
20.
Zurück zum Zitat Erdbruegger U, Grossheim M, Hertel B, et al. Diagnostic role of endothelial microparticles in vasculitis. Rheumatology (Oxford). 2008;47(12):1820–5.CrossRef Erdbruegger U, Grossheim M, Hertel B, et al. Diagnostic role of endothelial microparticles in vasculitis. Rheumatology (Oxford). 2008;47(12):1820–5.CrossRef
Metadaten
Titel
CD16+CD56+ cells are a potential culprit for hematuria in IgA nephropathy
verfasst von
Hirotsugu Iwatani
Yasuyuki Nagasawa
Ryohei Yamamoto
Kenichiro Iio
Masayuki Mizui
Arata Horii
Tadashi Kitahara
Hidenori Inohara
Atsushi Kumanogoh
Enyu Imai
Hiromi Rakugi
Yoshitaka Isaka
Publikationsdatum
01.04.2015
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 2/2015
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-014-0968-z

Weitere Artikel der Ausgabe 2/2015

Clinical and Experimental Nephrology 2/2015 Zur Ausgabe

Images in Nephrology

Renal arteriovenous fistula

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.